** Shares in Almirall ALM.MC jump 4.7%, at the top of the Madrid General Index .SMSI, after the Spanish drugmaker said its H1 net profit rose 72.1% year-on-year to 26.5 million euros ($31.12 million)
** The pharma company said its sales were boosted by strong Dermatology growth in Europe
** "We see robust +11% Net Sales growth with operating leverage driving an attractive +23.5% Adj. EPS CAGR over 2025-28E," Jefferies says
** Almirall also reiterated its 2025 guidance
** Shares are on track for their best day in more than three months
($1 = 0.8515 euros)
(Reporting by Javi West Larrañaga)
((javier.west@thomsonreuters.com; +34 918 35 61 12))